Product Program year 2020 Source: CMS Open Payments

Ezallor Sprinkle

Drug Cardiology/Vascular Diseases

NDC 47335-984-64

Open in the dashboard

General payments

$117,257

808 payments

Research payments

$0

0 payments

Through program year 2020, $117,257 in general payments and $0 in research payments were reported against Ezallor Sprinkle (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $65,387 601
2019 General $51,871 207

Breakdown

Who paid General payments · program years 2019–2020
  1. Sun Pharmaceutical Industries Inc. $117,257 808 payments
Top recipients General payments · program year 2020
  1. Christopher Chappel Family Medicine · Kissimmee, FL $32,985 50% · 42 payments
  2. Jeffrey Deitch Family Medicine · Sterling Heights, MI $8,287 13% · 16 payments
  3. Meenakshi Patel Geriatric Medicine · Centerville, OH $5,122 8% · 6 payments
  4. Albert Riddle Geriatric Medicine · Haworth, NJ $3,506 5% · 4 payments
  5. Alan Laszczynski Internal Medicine · West Columbia, SC $3,210 5% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Family Medicine $44,369 68% · 132 practitioners
  2. Geriatric Medicine Internal Medicine $9,605 15% · 22 practitioners
  3. Internal Medicine $7,037 11% · 151 practitioners
  4. Psychiatry Psychiatry & Neurology $964 1% · 43 practitioners
  5. Pulmonary Disease Internal Medicine $873 1% · 5 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $33,725 52% · 27 recipients
  2. Michigan $8,501 13% · 6 recipients
  3. Ohio $6,075 9% · 38 recipients
  4. New Jersey $3,737 6% · 14 recipients
  5. North Carolina $3,210 5% · 1 recipient

The top 5 of 32 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

808 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record